 | • レポートコード：MRC2-11QY05778 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は馬インフルエンザワクチンのグローバル市場について調査・分析したレポートです。種類別（液体、粉末）市場規模、用途別（家庭、ペットクリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別馬インフルエンザワクチンの競争状況、市場シェア ・世界の馬インフルエンザワクチン市場：種類別市場規模 2015年-2020年（液体、粉末） ・世界の馬インフルエンザワクチン市場：種類別市場規模予測 2021年-2026年（液体、粉末） ・世界の馬インフルエンザワクチン市場：用途別市場規模 2015年-2020年（家庭、ペットクリニック、その他） ・世界の馬インフルエンザワクチン市場：用途別市場規模予測 2021年-2026年（家庭、ペットクリニック、その他） ・北米の馬インフルエンザワクチン市場分析：米国、カナダ ・ヨーロッパの馬インフルエンザワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの馬インフルエンザワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の馬インフルエンザワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの馬インフルエンザワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Zoetis、Merck Animal Health、Boehringer Ingelheim Vetmedica ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Equine Influenza Vaccine Market
The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Equine Influenza Vaccine Scope and Market Size
Equine Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Equine Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Equine Influenza Vaccine market is segmented into
Liquid
Powder
Segment by Application, the Equine Influenza Vaccine market is segmented into
Home
Pet Clinic
Other
Regional and Country-level Analysis
The Equine Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Equine Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Equine Influenza Vaccine Market Share Analysis
Equine Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Equine Influenza Vaccine business, the date to enter into the Equine Influenza Vaccine market, Equine Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
…
1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Equine Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Liquid
1.4.3 Powder
1.5 Market by Application
1.5.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Home
1.5.3 Pet Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Equine Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Equine Influenza Vaccine Revenue 2015-2026
2.1.2 Global Equine Influenza Vaccine Sales 2015-2026
2.2 Global Equine Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Equine Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Equine Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Equine Influenza Vaccine Competitor Landscape by Players
3.1 Equine Influenza Vaccine Sales by Manufacturers
3.1.1 Equine Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Equine Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Equine Influenza Vaccine Revenue by Manufacturers
3.2.1 Equine Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Equine Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Equine Influenza Vaccine Revenue in 2019
3.2.5 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Equine Influenza Vaccine Price by Manufacturers
3.4 Equine Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Equine Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Equine Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Equine Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Equine Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Equine Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Equine Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Equine Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Equine Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Equine Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Equine Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Equine Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Equine Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Equine Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Equine Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Equine Influenza Vaccine Price by Application (2015-2020)
5.2 Equine Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Equine Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Equine Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Equine Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Equine Influenza Vaccine by Country
6.1.1 North America Equine Influenza Vaccine Sales by Country
6.1.2 North America Equine Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Equine Influenza Vaccine Market Facts & Figures by Type
6.3 North America Equine Influenza Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Equine Influenza Vaccine by Country
7.1.1 Europe Equine Influenza Vaccine Sales by Country
7.1.2 Europe Equine Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Equine Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Equine Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Equine Influenza Vaccine by Region
8.1.1 Asia Pacific Equine Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Equine Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Equine Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Equine Influenza Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Equine Influenza Vaccine by Country
9.1.1 Latin America Equine Influenza Vaccine Sales by Country
9.1.2 Latin America Equine Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Equine Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Equine Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Equine Influenza Vaccine by Country
10.1.1 Middle East and Africa Equine Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Equine Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Equine Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Equine Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Equine Influenza Vaccine Products Offered
11.1.5 Zoetis Related Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Description and Business Overview
11.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Animal Health Equine Influenza Vaccine Products Offered
11.2.5 Merck Animal Health Related Developments
11.3 Boehringer Ingelheim Vetmedica
11.3.1 Boehringer Ingelheim Vetmedica Corporation Information
11.3.2 Boehringer Ingelheim Vetmedica Description and Business Overview
11.3.3 Boehringer Ingelheim Vetmedica Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Products Offered
11.3.5 Boehringer Ingelheim Vetmedica Related Developments
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Equine Influenza Vaccine Products Offered
11.1.5 Zoetis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Equine Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Equine Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Equine Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Equine Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Equine Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Equine Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Equine Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Equine Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Equine Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Equine Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Equine Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Equine Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Equine Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Equine Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Equine Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Equine Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Equine Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Equine Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Equine Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Equine Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Equine Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Equine Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Equine Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Equine Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Equine Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Equine Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Equine Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Equine Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Liquid
Table 5. Major Manufacturers of Powder
Table 6. Global Equine Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Equine Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Equine Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 9. Global Equine Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Equine Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Equine Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Equine Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 13. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Influenza Vaccine as of 2019)
Table 15. Equine Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Equine Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 18. Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Equine Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Equine Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 23. Global Equine Influenza Vaccine Sales Share by Type (2015-2020)
Table 24. Global Equine Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Equine Influenza Vaccine Revenue Share by Type (2015-2020)
Table 26. Equine Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 28. Global Equine Influenza Vaccine Sales Share by Application (2015-2020)
Table 29. North America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 30. North America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 31. North America Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 33. North America Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 34. North America Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 35. North America Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 36. North America Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 37. Europe Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 38. Europe Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 39. Europe Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Europe Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 42. Europe Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 43. Europe Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 44. Europe Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Equine Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Equine Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 53. Latin America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 59. Latin America Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Equine Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Equine Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 69. Zoetis Corporation Information
Table 70. Zoetis Description and Major Businesses
Table 71. Zoetis Equine Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. Zoetis Product
Table 73. Zoetis Recent Development
Table 74. Merck Animal Health Corporation Information
Table 75. Merck Animal Health Description and Major Businesses
Table 76. Merck Animal Health Equine Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Merck Animal Health Product
Table 78. Merck Animal Health Recent Development
Table 79. Boehringer Ingelheim Vetmedica Corporation Information
Table 80. Boehringer Ingelheim Vetmedica Description and Major Businesses
Table 81. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Boehringer Ingelheim Vetmedica Product
Table 83. Boehringer Ingelheim Vetmedica Recent Development
Table 84. Global Equine Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 85. Global Equine Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 86. Global Equine Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 87. Global Equine Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 88. North America: Equine Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 89. North America: Equine Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Europe: Equine Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 91. Europe: Equine Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Asia Pacific: Equine Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 93. Asia Pacific: Equine Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Latin America: Equine Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 95. Latin America: Equine Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Middle East and Africa: Equine Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 97. Middle East and Africa: Equine Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Market Risks
Table 101. Main Points Interviewed from Key Equine Influenza Vaccine Players
Table 102. Equine Influenza Vaccine Customers List
Table 103. Equine Influenza Vaccine Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Influenza Vaccine Product Picture
Figure 2. Global Equine Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Equine Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Home
Figure 7. Pet Clinic
Figure 8. Other
Figure 9. Equine Influenza Vaccine Report Years Considered
Figure 10. Global Equine Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Equine Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 12. Global Equine Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 15. Global Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Equine Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Equine Influenza Vaccine Revenue in 2019
Figure 19. Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Equine Influenza Vaccine Sales Market Share by Type in 2019
Figure 22. Global Equine Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Equine Influenza Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Equine Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Equine Influenza Vaccine Sales Market Share by Application in 2019
Figure 27. Global Equine Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Equine Influenza Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 30. North America Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 32. North America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.S. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Canada Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Equine Influenza Vaccine Market Share by Type in 2019
Figure 38. North America Equine Influenza Vaccine Market Share by Application in 2019
Figure 39. Europe Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 40. Europe Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Germany Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. France Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 48. U.K. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. Italy Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Russia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Equine Influenza Vaccine Market Share by Type in 2019
Figure 54. Europe Equine Influenza Vaccine Market Share by Application in 2019
Figure 55. Asia Pacific Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 56. Asia Pacific Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 58. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 59. China Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 60. China Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. South Korea Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. India Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Australia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Taiwan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Indonesia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Thailand Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Malaysia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Philippines Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Vietnam Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Equine Influenza Vaccine Market Share by Type in 2019
Figure 82. Asia Pacific Equine Influenza Vaccine Market Share by Application in 2019
Figure 83. Latin America Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 84. Latin America Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 86. Latin America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 87. Mexico Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 88. Mexico Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 90. Brazil Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 92. Argentina Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Equine Influenza Vaccine Market Share by Type in 2019
Figure 94. Latin America Equine Influenza Vaccine Market Share by Application in 2019
Figure 95. Middle East and Africa Equine Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 96. Middle East and Africa Equine Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 99. Turkey Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 100. Turkey Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 102. Saudi Arabia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 104. U.A.E Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Equine Influenza Vaccine Market Share by Type in 2019
Figure 106. Middle East and Africa Equine Influenza Vaccine Market Share by Application in 2019
Figure 107. North America Equine Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 108. North America Equine Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Equine Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 110. Europe Equine Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Equine Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 112. Asia Pacific Equine Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Equine Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 114. Latin America Equine Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Equine Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. Middle East and Africa Equine Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
犬用インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Canine Influenza Vaccine Market The global Canine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Canine Influenza Vaccine Scope and Market Size Canine Influenza V…- 乗馬アパレル・ギアの世界市場（～2026年） Equine apparel and gear, also known as horse riding apparel, the horse riding apparel mainly composed by several body parts, like boots, helmets, breeches, etc. The purpose for wearing horse riding apparel was to provide safety and comfort for riders, also the horse riding apparel itself can represe…
- インフルエンザ診断の世界市場（～2026年） Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B viru…
- インフルエンザワクチン接種の世界市場（～2026年） Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, …
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…